RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PRTA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Prothena Corporation plc stock price after Wednesday trading.
(Updated on Mar 27, 2024)

Sell candidate since Mar 25, 2024 Loss -0.94% PDF

The Prothena Corporation plc stock price gained 1.66% on the last trading day (Wednesday, 27th Mar 2024), rising from $24.75 to $25.16. During the last trading day the stock fluctuated 4.54% from a day low at $24.46 to a day high of $25.57. The price has fallen in 5 of the last 10 days and is down by -12.03% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 thousand more shares were traded than the day before. In total, 597 thousand shares were bought and sold for approximately $15.02 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -29.29% during the next 3 months and, with a 90% probability hold a price between $16.55 and $20.83 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PRTA Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 1.66%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Prothena Corporation plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $25.35 and $27.41. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Prothena Corporation plc stock

Prothena Corporation plc finds support from accumulated volume at $25.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.11 between high and low, or 4.54%. For the last week, the stock has had daily average volatility of 5.13%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PRTA) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Prothena Corporation plc to open at $25.06, and during the day (based on 14 day Average True Range), to move between $23.63 and $26.69, which gives a possible trading interval of +/-$1.53 (+/-6.08%) up or down from last closing price. If Prothena Corporation plc takes out the full calculated possible swing range there will be an estimated 12.16% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $25.09 (0.28%) than the resistance at $26.07 (3.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Prothena Corporation plc stock A Buy?

Prothena Corporation plc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.247 Sell Candidate Upgraded

Predicted Opening Price for Prothena Corporation plc of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$25.06 ( 0.384%) $25.16

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PRTA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 26.17 4.03 %
R2 25.75 2.34 %
R1 25.49 1.30 %
Current price: 25.16
Support S1 24.64 -2.07 %
S2 24.38 -3.11 %
S3 23.95 -4.80 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 29.86 18.68 %
R2 28.39 12.84 %
R1 26.07 3.62 %
Current price 25.16
Support S1 25.09 -0.278%
S2 25.05 -0.437%
S3 24.75 -1.63%

FAQ

What is the symbol for Prothena Corporation plc Stock and on which exchange is it traded?
The symbol for Prothena Corporation plc is PRTA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Prothena Corporation plc Stock?
Prothena Corporation plc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Prothena Corporation plc Stock?
Prothena Corporation plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Prothena Corporation plc Stock.

What's the current price of Prothena Corporation plc Stock?
As of the end of day on the 2024-03-27, the price of an Prothena Corporation plc (PRTA) share was $25.16.

What is the 52-week high and low for Prothena Corporation plc Stock?
The 52-week high for Prothena Corporation plc Stock is $79.64 and the 52-week low is $24.29.

What is the market capitalization of Prothena Corporation plc Stock?
As of the 2024-03-27, the market capitalization of Prothena Corporation plc is 1.352B.

When is the next earnings date for Prothena Corporation plc?
The upcoming earnings date for Prothena Corporation plc is May 02, 2024.
Click to get the best stock tips daily for free!

About Prothena Corporation plc

Prothena  plc Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease... PRTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT